References
| Author (yr) | Title | Citation | Isolate |
|---|---|---|---|
| Seatla (2018) | Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana. | AIDS | PR HIV1 group M: 4 RT HIV1 group M: 4 IN HIV1 group M: 2 |